Navigation Links
The Colorado Institute for Drug, Device and Diagnostic Development Announces Companies Selected From Its First Solicitation: Sophono, Inc., Receiving $600K; and PeptiVir, Inc., $300K
Date:9/27/2010

AURORA, Colo., Sept. 27 /PRNewswire/ -- The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has completed the selection process from its first solicitation announced in February.  The announcement is made by Richard C. Duke, Ph.D., CID4 President/CEO, who says, "Boulder-based Sophono, Inc., is receiving $600,000 for its Alpha 1 Magnetic Bone Anchored Hearing System; and Aurora-based PeptiVir, Inc., is receiving $300,000 for its universal flu vaccine under development."

In addition to initial financial support from the state, CID4 also received federal support from Fitzsimons Redevelopment Authority via a Senate appropriation supported by Colorado Senator Michael Bennet.  Senator Bennet says, "We can strengthen our economic recovery and ensure Colorado remains a leader in innovation and entrepreneurship by supporting efforts that turn groundbreaking research into startups and companies that will grow and create good-paying jobs."

Further, Colorado Governor Bill Ritter, says: "Supporting Colorado's life sciences companies is critical to growing jobs and our economy in Colorado, and I congratulate both the CID4 for success in its first solicitation and those companies chosen to receive funding."

"Sophono's Alpha 1 has received its CE mark and is being sold in Europe.  Our investment will allow Sophono to accelerate its FDA clearance process," Kevin M. Smith, CID4 Executive Vice President/COO, explains. In addition, according to Sophono's President/CEO Jim Kasic, the company plans to relocate manufacturing and assembling operations from Germany to Boulder, resulting in the hiring of 6-10 employees. Visit http://www.sophono.com.  

PeptiVir, Inc., is an early stage biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for prevention of viral diseases. "There is an urgent need to develop new and different influenza vaccines," Kathryn Holmes, Professor of Microbiology, University of Colorado School of Medicine and a PeptiVir founder, says.  

About CID4

CID4 is transforming life science innovation into commercial success by identifying and funding potential opportunities, and utilizing the talents of an advanced leadership team to ensure ultimate market value. Visit http://www.cid4.com.


'/>"/>
SOURCE The Colorado Institute for Drug, Device and Diagnostic Development
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
2. American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver
3. Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens
4. Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings
5. Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
6. Forensic Laboratories Selected for Colorado Companies to Watch Award
7. CO-REC Ready to Assist Colorado Health Care Providers in Implementing Electronic Health Record Systems and Achieving Meaningful Use
8. Tahoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated
9. Tacoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated
10. AlloSource Named Colorados Top Healthcare Company
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
(Date:12/8/2016)... 2016 A Small Business Innovative Research (SBIR) ... Health (NIH) to Phoenix -based NeuroEM ... The grant will seek to determine an optimal set ... electromagnetic waves to treat Alzheimer,s Disease. The grant will ... possibly treat other neurologic disorders such as Parkinson,s Disease ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... of access for customers and employees that are both engaging and easy to ... Service Smart Technology, the software company revealed today its plans to roll out ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it had joined the Pharmaceutical Supply ... non-profit organization to unite pharmaceutical and healthcare companies that share a vision of ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to announce ... service for Texas, they are expanding their presence in Dallas. One of the most ... will bring new jobs to the Dallas and Forth Worth market. STAT takes pride ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
Breaking Medicine News(10 mins):